Position in ABBV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$569,964
+$66,040 QoQ
Shares Held
2,265
-2.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#3,046
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SAGE RHINO CAPITAL LLC holds $11,215,095 across 12 Drug Manufacturers - General names. ABBV ranks #8 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,014 | $2,415,652 | |
| 2 | JNJ |
Johnson & Johnson
|
6,868 | $1,744,265 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,448 | $1,342,568 | |
| 4 | NVS |
Novartis AG
|
7,947 | $1,245,453 | |
| 5 | AZN |
Astrazeneca PLC
|
5,336 | $1,011,812 | |
| 6 | AMGN |
Amgen Inc
|
2,387 | $864,380 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
5,127 | $647,745 | |
| 8 | ABBV |
AbbVie Inc.
This page
|
2,265 | $569,964 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $569,964 | 2,265 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $503,924 | 2,317 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $530,782 | 2,323 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $562,642 | 2,430 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $427,854 | 2,305 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $481,896 | 2,300 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $411,730 | 2,317 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $470,002 | 2,380 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $420,395 | 2,451 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $427,752 | 2,349 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $350,852 | 2,264 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $343,583 | 2,305 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $306,780 | 2,277 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $427,589 | 2,683 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $374,127 | 2,315 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $310,964 | 2,317 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $381,062 | 2,488 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $453,259 | 2,796 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $383,317 | 2,831 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $297,289 | 2,756 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $302,438 | 2,685 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $284,185 | 2,626 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $277,089 | 2,586 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $223,967 | 2,557 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $251,537 | 2,562 | Shares | Sole | 2020-07-30 | |
| No filing history on record for this holder in this stock. | ||||||